|
|
|
|
|
|
|
Name of Company
|
|
Place and Date of
Incorporation /
Acquisition
|
|
Attributable
Equity Interest Held |
|
Principal Activity
|
WuXi AppTec (BVI) Inc. (“WXAT BVI”)
|
|
British Virgin Islands
June 3, 2004
|
|
100% |
|
Holding company of People’s Republic of
China(“PRC”) subsidiaries |
WuXi AppTec Co., Ltd. (“WXAT”)
|
|
PRC
July 13, 2005
|
|
100% |
|
Laboratory services to pharmaceutical and
biotechnology industries |
WuXi AppTec (Shanghai) Co., Ltd. (“WASH”)
|
|
PRC
April 2, 2002
|
|
100% |
|
Laboratory services to pharmaceutical and
biotechnology industries |
Shanghai SynTheAll Pharmaceutical Co., Ltd. (“STA”)
|
|
PRC
January 23, 2003
|
|
100% |
|
Pharmaceutical manufacturing |
WuXi AppTec (Suzhou) Co., Ltd. (“WASZ”)
|
|
PRC
October 8, 2006
|
|
100% |
|
Laboratory services to pharmaceutical and
biotechnology industries |
WuXiAppTec (Tianjin) Co., Ltd. (“WATJ”)
|
|
PRC
June 5, 2006
|
|
100% |
|
Laboratory services to pharmaceutical and
biotechnology industries |
WuXi AppTec Holding Company, Inc. (“AppTec
Holding”)
|
|
United States of America (“United States” or
“U.S.”)
January 3, 2008
|
|
100% |
|
Holding company of U.S. subsidiaries |
WuXi AppTec, Inc. (“AppTec”)
|
|
United States
January 3, 2008
|
|
100% |
|
Laboratory services to biotechnology and medical
device industries |
WX (BVI), Ltd.
|
|
British Virgin Islands
July 4, 2008
|
|
100% |
|
Holding company of European subsidiaries |
Kaipara Enterprises Ltd.
|
|
Cyprus
July 14, 2008
|
|
100% |
|
Shell company |
Klivia Investments Sp. Z o.o.
|
|
Poland
July 31, 2008
|
|
100% |
|
Intermediate holding company |
WuXi AppTec Biopharmaceuticals Co., Ltd. (“WABIO”)
|
|
PRC
May 25, 2010
|
|
100% |
|
Biologics manufacturing |
WuXi AppTec (Wuhan) Co., Ltd. (“WAWH”)
|
|
PRC
November 30, 2010
|
|
100% |
|
Laboratory services to pharmaceutical and
biotechnology industries |
Shanghai AppTec (HK) Ltd.
|
|
Hong Kong
December 10, 2010
|
|
100% |
|
Shell company |
Global Bond Investments Ltd.
|
|
Hong Kong
December 8, 2010
|
|
100% |
|
Investment management |
Chemdepo, Inc. (“Chemdepo”)
|
|
United States
March 30, 2011
|
|
100% |
|
Radioactive chemistry compound synthesis service
to pharmaceutical and biotechnology industries |
WuXi AppTec UK, Inc. (“AppTec UK”)
|
|
United Kingdom
January 17, 2011
|
|
100% |
|
Sales company |
WuXi AppTec Sales, LLC (“AppTec Sales”)
|
|
United States
January 19, 2011
|
|
100% |
|
Sales company |
STA Pharmaceutical Hong Kong Ltd. (“STA HK”)
|
|
Hong Kong
April 12, 2011
|
|
100% |
|
Sales company |
Shanghai STA Pharmaceutical R&D Co., Ltd. (“STA
R&D”)
|
|
PRC
April 15, 2011
|
|
100% |
|
Pharmaceutical process development and
manufacturing |
WuXi PharmaTech Investment Holdings (Cayman) Inc.
|
|
United States
May 24, 2011
|
|
100% |
|
Investment holding company |
WuXi PharmaTech Investments (Cayman) Inc.
|
|
Cayman Islands
May 24, 2011
|
|
100% |
|
Investment management |
WuXi PharmaTech Fund I General Partner L.P.
|
|
Cayman Islands
May 24, 2011
|
|
100% |
|
Investment management |
WuXi PharmaTech Investment Management (Cayman) Inc.
|
|
Cayman Islands
May 24, 2011
|
|
100% |
|
Investment management |
WuXi PharmaTech Healthcare Fund I L.P.
|
|
Cayman Islands
May 24, 2011
|
|
100% |
|
Corporate venture investment (U.S. dollar
fund) |
Wuxi AppTec Investment & Development Co., Ltd.
|
|
PRC
June 29, 2011
|
|
100% |
|
Investment management |
WuXi AppTec Biomedical Investment Management L.P.
|
|
PRC
July 18, 2011
|
|
100% |
|
Investment management |
WuXi AppTec Equity Investment Management Co., Ltd.
|
|
PRC
August 11, 2011
|
|
100% |
|
Investment management |
WuXi AppTec Investment Fund I L.P.
|
|
PRC
August 16, 2011
|
|
100% |
|
Corporate venture investment (RMB fund) |
Abgent, Inc.
|
|
United States
October 14, 2011
|
|
100% |
|
Biologics reagent research and sales |
Abgent Europe Ltd.
|
|
United Kingdom
October 14, 2011
|
|
100% |
|
Biologics reagent sales |
Abgent Biotechnology (Suzhou) Co., Ltd. (“Abgent
Suzhou”)
|
|
PRC
October 14, 2011
|
|
100% |
|
Biologics reagent development and production |
MedKey Med-Tech Development Co., Ltd.
|
|
PRC
October 31, 2011
|
|
100% |
|
Clinical research |
SynTheAll (Changzhou) Pharmaceutical R&D Co., Ltd
|
|
PRC
December 15, 2011
|
|
100% |
|
Pharmaceutical manufacturing |
MedIShine Discovery, Inc.
|
|
PRC
December 16, 2011
|
|
100% |
|
Testing services
(no activity in 2014)
|
WuXi AppTec (Hong Kong) Ltd.
|
|
Hong Kong
March 26, 2012
|
|
100% |
|
Sales company |
WuXi AppTec (Suzhou) Testing Technology Co., Ltd.
|
|
PRC
May 30, 2012
|
|
100% |
|
Testing services |
WuXi AppTec (Haimen) Co., Ltd.
|
|
PRC
July 2, 2012
|
|
100% |
|
Pharmaceutical manufacturing
(no activity in 2014)
|
Changzhou SynTheAll Pharmaceutical Co., Ltd.
|
|
PRC
September 29, 2013
|
|
100% |
|
Pharmaceutical manufacturing
(no activity in 2014)
|
WuXi Biologics Holdings Co., Ltd.
|
|
PRC
August 14, 2014
|
|
100% |
|
Sales company |
WuXi AppTec LN (Cayman) Inc.
|
|
Cayman Islands
July 23, 2014
|
|
100% |
|
Shell company |
LabNetwork B.V.
|
|
Netherlands
December 12, 2014
|
|
100% |
|
E-commerce |
LabNetwork Inc.
|
|
United States
November 14, 2014
|
|
100% |
|
E-commerce |
XenoBiotic Laboratories, Inc.
|
|
United States
September 30, 2014
|
|
100% |
|
Testing services |
Sino Path Holdings Ltd.
|
|
British Virgin Islands
September 30, 2014
|
|
100% |
|
Sales company |
XBL (BVI) Ltd.
|
|
British Virgin Islands
September 30, 2014
|
|
100% |
|
Sales company |
XBL-HK, Ltd.
|
|
Hong Kong
September 30, 2014
|
|
100% |
|
Sales company |
XBL-China, Inc.
|
|
PRC
September 30, 2014
|
|
100% |
|
Testing services |
WuXi AppTec (Shanghai) Investment Management Co., Ltd.
|
|
PRC
September 19, 2014
|
|
100% |
|
Investment management |
WuXi AppTec Lab Testing and Diagnosis (Shanghai) Co., Ltd.
|
|
PRC
October 17, 2014
|
|
100% |
|
Testing services |
WuXi Genomics, Inc.
|
|
Cayman Islands
December 18, 2014
|
|
100% |
|
Investment management |
WuXi Biologics (Cayman) Inc.
|
|
Cayman Islands
February 27, 2014
|
|
100% |
|
Shell company |
WuXi Biologics (Hong Kong) Ltd.
|
|
Hong Kong
May 12, 2014
|
|
100% |
|
Sales company |